Actively Recruiting
Non-small Cell Lung Cancer With Central Nervous System Metastasis
Led by National Taiwan University Hospital · Updated on 2023-09-07
30
Participants Needed
1
Research Sites
254 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Cerebrospinal fluid was obtained from the cerebrospinal cavity of non-small cell lung cancer patients with central nervous system metastasis, blood was obtained from veins, and metastatic lung cancer tumor tissue was obtained from surgically resected brain tumors or meningeal tumors. Then comprehensively analyze the exosomes contained in the aforementioned samples, and compare and analyze the clinical data of the patients, so as to explore whether the cancer cell-related substances contained in the cerebrospinal fluid, blood and tumor tissue can be used to predict lung cancer metastasis and Bioindicators of treatment effect.
CONDITIONS
Official Title
Non-small Cell Lung Cancer With Central Nervous System Metastasis
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Non-small cell lung cancer patients diagnosed with brain or meningeal metastases confirmed by brain CT or MRI images
- Patients scheduled for brain surgery including tumor removal, lumbar abdominal drainage, Euclidean storage, or ventriculoperitoneal drainage
You will not qualify if you...
- Non-small cell lung cancer patients without brain or meningeal metastases
- Patients whose physical condition does not allow surgical tumor removal
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
National Taiwan University Hospital
Taipei, Taiwan, 100
Actively Recruiting
Research Team
A
ABEL HUANG, MD
CONTACT
A
ABEL HUANG
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here